Hey
@dougfr
It depends on the audience they're presenting to - admittedly, a room of scientists would be TK's environment and BL would probably be the first to say that.
With their travel/FDA schedule ATM I'd guess TK doesn't have the capacity but I've seen both present and honestly, each has their strength’s mate.
From BL's same preso and in the AFR article today
"(ResApp)
could be the biggest disruption in healthcare since the invention of the stethoscope"
I cannot imagine TK ever saying this publicly, but it’s polarizing and absolutely key for commercialisation.
This thing is revolutionary but once the regulatory process is assured we're gonna need some sizzle and BL's ‘passion’ might just be what's needed to gain the attention of someone influential.
Who right now? Maybe a HNW/Soph investor sitting at a lunch presentation in Hong Kong that could tip in a lazy few mil for an off-market transfer with an escrow holder(s) that doesn’t have day-to-day involvement with the company.
